Poster presentations: Clinical
21 Posters
Pregnancy safety outcomes in subcutaneous interferon-beta-exposed patients with multiple sclerosis: Results from GCC region
Amir Boshra
13
Diffuse B giant cell lymphoma associated with fingolimod treatment in Multiple Sclerosis: a case report
Young Investigator
Adriana Casallas Vanegas
60
Concomitant onset of Multiple Sclerosis and celiac disease: association or new disease entity?
Young Investigator
Gaia Cola
39
Stable vs. Silent progressive Multiple Sclerosis: A real world retrospective clinical imaging Brazilian study
Young Investigator
Raquel Custódio Da Silveira
03
Identifying distinct cognitive phenotypes in multiple sclerosis
Young Investigator
Ermelinda De Meo
50
A Genome-Wide Association Study highlights a possible involvement of mast cells and neutrophils in disease activity in multiple sclerosis
Young Investigator
Antonino Giordano
65
Autonomic nervous system abnormalities may predict cardiovascular changes after initiation of siponimod in the treatment of secondary progressive multiple sclerosis
Mario Habek
82
CogEval project: tackling unmet multiple sclerosis-related cognitive challenges
Andres Labiano
41
A real-world study characterizing symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis using a novel disease specific scale
Lindsey Lair
38
Efficacy of high-intensity aerobic exercise on fatigue, walking, and quality of life in people with multiple sclerosis: A randomized controlled trial
Winner Young Investigator Award
Young Investigator
Martin Langeskov-Christensen
26
Interrelation between INF-γ levels and severity of electrodiagnostic abnormality in acute phase of Bell’s palsy
Mehdi Maghbooli
73
Information in Multiple Sclerosis: do people with MS want to know about their disease?
Young Investigator
Elisa Matias Vieira de Melo
12
Central and peripheral (CCDP) demyelination in a patient with MOGAD disease(MOG Antibody disease)
Young Investigator
Konstantinos Melanis
53
Clinical utility of the Processing Speed Test in patients with multiple sclerosis
Yusei Miyazaki
76
Clinical relapse rates in relapsing multiple sclerosis patients treated with the BTK inhibitor evobrutinib: results of an open-label extension to a Phase II study
Xavier Montalban
31
Clinical characteristics of patients with late-onset NMOSD in a Japanese cohort
Young Investigator
Akihiro Nakajima
84
A study of developing standard data of cognitive function using Processing Speed Test in Japanese healthy volunteers
Masaaki Niino
94
Predominant cognitive phenotypes in MS: insights from patient-centered outcomes (PCOs)
Young Investigator
Jessica Podda
70
Anti-NMDAR autoimmune encephalitis in Covid-19 pneumonia patient
Young Investigator
Erasmo Ramos
42
Serum Immunoglobulin Levels and Infections in Relapsing Multiple Sclerosis
Heinz Wiendl
33